symbol,statement_type,period_end,line_item,value
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,1715010000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Repurchase Of Capital Stock,
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,0.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-79200000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,End Cash Position,2174860000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,1761380000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,21840000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,391640000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-870970000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-33040000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-775990000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Common Stock Payments,
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,0.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,0.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,0.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-531600000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,93550000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,132520000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,6356130000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-6223610000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-78490000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,710000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-79200000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,1794210000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-407360000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,348160000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,-96080000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-157350000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Change In Payable,332360000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,182100000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-49590000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,82120000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,393070000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Depreciation,393070000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-26700000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,43380000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-270000.0
EXPLEOSOL.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,1392400000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,538630000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Repurchase Of Capital Stock,
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-4710000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-174830000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,End Cash Position,1761380000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,1525310000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,-12170000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,248240000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-152010000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-24820000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-77600000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Common Stock Payments,
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-4710000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-4710000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-4710000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-313210000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,54070000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-197530000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,4797980000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-4995510000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-169750000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,5080000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-174830000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,713460000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-415220000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-406920000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,-79140000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,123570000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Change In Payable,-348150000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,0.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-152360000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-43280000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,10350000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,336660000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Depreciation,336660000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-280000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,34690000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,1720000.0
EXPLEOSOL.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,1195740000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-211140000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Repurchase Of Capital Stock,
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-640000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,0.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-441950000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,End Cash Position,1525310000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,1730800000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,-10710000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-194780000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-65710000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-13610000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Common Stock Payments,
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,-640000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,-640000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-640000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,0.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-359880000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,39530000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,33160000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,1919090000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-1885930000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-432570000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,9380000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-441950000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,230810000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-460210000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-1450710000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-4220000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-363450000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Change In Payable,-74400000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,22700000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-976620000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-17890000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,11180000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,278840000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Depreciation,278840000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,17010000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,-8470000.0
EXPLEOSOL.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,1861060000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-11930000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Repurchase Of Capital Stock,
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-5240000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,4570000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-254280000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,End Cash Position,1730800000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,1558430000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,-8010000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,180380000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-103640000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-8630000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Common Stock Payments,
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-670000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-670000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-5240000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,4570000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,41670000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,23930000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,268550000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,668070000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-399520000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-250810000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,3470000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-254280000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,242350000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-273170000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,581620000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-53840000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-286620000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Change In Payable,505900000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-22700000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,415370000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,-1348720000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,290000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,187640000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,2330000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Depreciation,187640000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-5580000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-800000.0
EXPLEOSOL.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,1101070000.0
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Repurchase Of Capital Stock,0.0
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,0.0
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Common Stock Payments,0.0
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,-153230000.0
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,660000.0
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,2680000.0
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Depreciation,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
EXPLEOSOL.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
